-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Phathom Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
- Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $5.64M, a 8.23% decline year-over-year.
- Phathom Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $41.9M, a 54.8% increase year-over-year.
- Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45M, a 86.6% increase from 2022.
- Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $24.1M, a 43.5% increase from 2021.
- Phathom Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16.8M, a 188% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)